Validation of a comorbidity index for use in obstetric patients: A nationwide cohort study

被引:21
|
作者
Bliddal, Mette [1 ,2 ]
Moller, Soren [1 ,2 ]
Vinter, Christina A. [1 ,3 ]
Rubin, Katrine H. [1 ,2 ]
Gagne, Joshua J. [4 ,5 ]
Pottegard, Anton [6 ]
机构
[1] Univ Southern Denmark, Dept Clin Res, Odense, Denmark
[2] Odense Univ Hosp, OPEN Open Patient Data Explorat Network, JB Winslow Vej 9a, DK-5000 Odense C, Denmark
[3] Odense Univ Hosp, Dept Obstet & Gynecol, Odense, Denmark
[4] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[5] Harvard Med Sch, Boston, MA 02115 USA
[6] Univ Southern Denmark, Dept Publ Hlth, Clin Pharmacol, Odense, Denmark
关键词
adverse maternal outcomes; comorbidity; obstetric comorbidity index; prediction; reproduction; validation; DANISH; DIAGNOSES; REGISTRY; RISK;
D O I
10.1111/aogs.13749
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction A previously developed Obstetric Comorbidity Index has been validated in highly selected cohorts. Validation of the index in an unselected population as well as in other health registers is, however, of high importance to determine external validity. Material and methods Using nationwide registers, we formed a nationwide cohort including completed pregnancies (both live- and stillborn) in Denmark from 2000 through 2014. Maternal age and 20 comorbid conditions were assessed and weighted. Outcomes were maternal end-organ injury or death within 30 days postpartum. The index's predictive and discriminative ability was estimated by Brier score and the area under the receiver operating characteristic curve (AUC), respectively. Logistic regression analysis was used to estimate odds ratios (OR) with 95% confidence interval (CI). Results In 876 496 completed pregnancies by 527 079 women, 1.40% (n = 12 314) experienced an outcome. The majority of women (64.1%) did not have any record of a condition included in the index and only 0.3% (n = 3044) had a score >6. The incidence of an outcome increased with increasing comorbidity score from 0.9% (95% CI 0.8-0.9) in women scoring 0% to 10.4% (95% CI 7.6-13.9) in women scoring 9-10. Compared with women scoring 0, a score of 1-2 yielded an OR of 2.34 (95% CI 2.25-2.44), 3-4 an OR of 5.16 (95% CI 4.81-5.54), 5-6 an OR of 4.84 (95% CI 4.31-5.44), and 8-9 an OR of 7.97 (95% CI 6.54-9.72) for experiencing the outcome. The index had a Brier score of 0.01 and an AUC of 0.64. Conclusions Despite potential weaknesses in the outcome definition, the Obstetric Comorbidity Index showed a moderate ability to discriminate and predict end-organ injury and death in a nationwide cohort in Denmark, in accordance with previous findings. These results suggest that the index may be a useful tool to control for confounding in health research and clinically to identify women at high risk for adverse maternal outcomes.
引用
收藏
页码:399 / 405
页数:7
相关论文
共 50 条
  • [21] VALIDATION OF A COMBINED COMORBIDITY INDEX
    CHARLSON, M
    SZATROWSKI, TP
    PETERSON, J
    GOLD, J
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) : 1245 - 1251
  • [22] The interaction effect between myocardial infarction and comorbidity: nationwide cohort study
    Schmidt, M.
    Horvath-Puho, E.
    Ording, A. G.
    Lash, T. L.
    Botker, H. E.
    Sorensen, H. T.
    EUROPEAN HEART JOURNAL, 2019, 40 : 1287 - 1287
  • [23] Comorbidity in congenital hypothyroidism - A nationwide population-based cohort study
    Danner, Emmi
    Jaaskelainen, Jarmo
    Huopio, Hanna
    Niuro, Laura
    Niinikoski, Harri
    Kero, Jukka
    Sund, Reijo
    HORMONE RESEARCH IN PAEDIATRICS, 2022, 95 (SUPPL 2): : 24 - 25
  • [24] Impact of comorbidity on renal cell carcinoma prognosis: a nationwide cohort study
    Horsbol, T. A.
    Dalton, S. O.
    Christensen, J.
    Petersen, A. C.
    Azawi, N.
    Donskov, F.
    Holm, M. L.
    Norgaard, M.
    Lund, L.
    ACTA ONCOLOGICA, 2022, 61 (01) : 58 - 63
  • [25] Psychiatric comorbidity among women with endometriosis: nationwide cohort study in Sweden
    Gao, Menghan
    Koupil, Ilona
    Sjoqvist, Hugo
    Karlsson, Hakan
    Lalitkumar, Sujata
    Dalman, Christina
    Kosidou, Kyriaki
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 223 (03) : 415.e1 - 415.e16
  • [26] Identification of herpes zoster high-risk group using Charlson comorbidity index: A nationwide retrospective cohort study
    Cho, Soo Ick
    Lee, Dong Hun
    Park, Young Min
    JOURNAL OF DERMATOLOGY, 2020, 47 (01): : 47 - 53
  • [27] Comorbidity in Patients with Dhat Syndrome: A Nationwide Multicentric Study
    Grover, Sandeep
    Avasthi, Ajit
    Gupta, Sunil
    Dan, Amitava
    Neogi, Rajarshi
    Behere, Prakash B.
    Lakdawala, Bhavesh
    Tripathi, Adarsh
    Chakraborty, Kaustav
    Sinha, Vishal
    Bhatia, Manjeet Singh
    Pattojoshi, Amrit
    Rao, T. S. S.
    Rozatkar, Abhijit
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 (06): : 1398 - 1401
  • [28] The medication-based Rx-Risk Comorbidity Index and risk of hip fracture - a nationwide NOREPOS cohort study
    Solbakken, Siri Marie
    Meyer, Haakon Eduard
    Dahl, Cecilie
    Finnes, Trine Elisabeth
    Hjellvik, Vidar
    Nielsen, Christopher Sivert
    Omsland, Tone Kristin
    Stigum, Hein
    Holvik, Kristin
    BMC MEDICINE, 2024, 22 (01)
  • [29] The medication-based Rx-Risk Comorbidity Index and risk of hip fracture - a nationwide NOREPOS cohort study
    Siri Marie Solbakken
    Haakon Eduard Meyer
    Cecilie Dahl
    Trine Elisabeth Finnes
    Vidar Hjellvik
    Christopher Sivert Nielsen
    Tone Kristin Omsland
    Hein Stigum
    Kristin Holvik
    BMC Medicine, 22
  • [30] Obstetric comorbidity index and the odds of general vs. neuraxial anesthesia in women undergoing cesarean delivery: a retrospective cohort study
    Singh, S.
    Farber, M. K.
    Bateman, B. T.
    Lumbreras-Marquez, M. I.
    Richey, C. J.
    Easter, S. R.
    Fields, K. G.
    Tsen, L. C.
    INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA, 2022, 51